Madurella mycetomatis compounds cross-reactive with galactomannan are detectable in culture supernatant but not in serum

References

1. Ahmed A. O., van Leeuwen W., Fahal A., van de Sande W., Verbrugh H., van Belkum A. 2004; Mycetoma caused by Madurella mycetomatis : a neglected infectious burden. Lancet Infect Dis 4:566–574 [CrossRef]
   [Google Scholar]
2. Becker M. J., Lugtenburg E. J., Cornelissen J. J., Van Der Schee C., Hoogsteden H. C., De Marie S. 2003; Galactomannan detection in computerized tomography-based broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis. Br J Haematol 121:448–457 [CrossRef]
   [Google Scholar]
3. Dalle F., Charles P. E., Blanc K., Caillot D., Chavanet P., Dromer F., Bonnin A. 2005; Cryptococcus neoformans galactoxylomannan contains an epitope(s) that is cross-reactive with Aspergillus galactomannan. J Clin Microbiol 43:2929–2931 [CrossRef]
   [Google Scholar]
4. Marr K. A., Laverdiere M., Gugel A., Leisenring W. 2005; Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin Infect Dis 40:1762–1769 [CrossRef]
   [Google Scholar]
5. Mennink-Kersten M. A., Donnelly J. P., Verweij P. E. 2004; Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis 4:349–357 [CrossRef]
   [Google Scholar]
6. Park Y. I., Buszko M. L., Gander J. E. 1997; Utilization of phosphocholine from extracellular complex polysaccharide as a source of cytoplasmic choline derivatives in Penicillium fellutanum . J Bacteriol 179:1186–1192
   [Google Scholar]
7. Swanink C. M., Meis J. F., Rijs A. J., Donnelly J. P., Verweij P. E. 1997; Specificity of a sandwich enzyme-linked immunosorbent assay for detecting Aspergillus galactomannan. J Clin Microbiol 35:257–260
   [Google Scholar]
8. van de Sande W. W., Luijendijk A., Ahmed A. O., Bakker-Woudenberg I. A., van Belkum A. 2005; Testing of the in vitro susceptibilities of Madurella mycetomati s to six antifungal agents by using the sensititre system in comparison with a viability-based 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay and a modified NCCLS method. Antimicrob Agents Chemother 49:1364–1368 [CrossRef]
   [Google Scholar]
9. Verweij P. E., Weemaes C. M., Curfs J. H., Bretagne S., Meis J. F. 2000; Failure to detect circulating Aspergillus markers in a patient with chronic granulomatous disease and invasive aspergillosis. J Clin Microbiol 38:3900–3901
   [Google Scholar]